The Biology of Breast Tumor Progression: Acquisition of hormone independence and resistance to cytotoxic drugs

References

• Miller A B, Bulbrook R D. UICC multidisciplinary project on breast cancer: the epidemiology, aetiology and prevention of breast cancer. Int J Cancer 1986; 37: 173–7
   PubMed Web of Science ®Google Scholar
• King R JB, Stewart J F, Millis R R, Rubens R D, Hayward J L. Quantitative comparison of estradiol and progesterone receptor contents of primary and metastatic human breast tumors in relation to response to endocrine treatment. Breast Cancer Res Treat 1982; 2: 339–46
   Google Scholar
• Clark G M, McGuire W L. Steroid receptors and other prognostic factors in primary breast cancer. Semin Oncol 1988; 15: 20–5
   PubMed Web of Science ®Google Scholar
• Goldstein L J, Galski H, Fojo A, et al. Expression of a multidrug resistance gene in human cancers. JNCI 1989; 81: 116–24
   PubMed Web of Science ®Google Scholar
• Salmon S E, Grogan T M, Miller T, Scheper R, Dalton W S. Prediction of doxorubicin resistance in vitro in myeloma, lymphoma and breast cancer by P-glycoprotein staining. JNCI 1989; 81: 696–701
   PubMed Web of Science ®Google Scholar
• Kacinski B M, Yee L D, Carter D, Li D, Kuo M T. Human breast carcinoma cell levels of MDR-I (P-glycoprotein) transcripts correlate in vivo inversely and reciprocally with tumor progesterone receptor content. Cancer Commun 1989; 1: 1–6
   PubMedGoogle Scholar
• Fidler I J, Hart R I. Biological diversity in metastatic neoplasms: origins and implications. Science 1982; 217: 998–1003
   PubMed Web of Science ®Google Scholar
• Clark G M, McGuire W L. Progesterone receptors and human breast cancer. Breast Cancer Res Treat 1983; 3: 157–63
   PubMed Web of Science ®Google Scholar
• Rio M C, Bellocq J P, Gairard B, et al. Specific expression of the pS2 gene in subclasses of breast cancers in comparison with expression of the estrogen and progesterone receptors and the oncogene ERBB2. Proc Natl Acad Sci USA 1987; 84: 9243–7
   PubMed Web of Science ®Google Scholar
• De Larco J E, Todaro G J. Growth factors from murine sarcoma virus-transformed cells. Proc Natl Acad Sci USA 1978; 75: 4001–5
   PubMed Web of Science ®Google Scholar
• Lippman M E, Dickson R B, Kasid A, et al. Autocrine and paracrine growth regulation of human breast cancer. J Steroid Biochem 1986; 24: 174–54
   Google Scholar
• Browder T M, Dunbar C E, Nienhuis A W. Private and public autocrine loops in neoplastic cells. Cancer Cells 1989; 1: 9–17
   PubMed Web of Science ®Google Scholar
• Dickson R B, McManaway M E, Lippman M E. Estrogen-induced factors of breast cancer cells partially replace estrogen to promote tumor growth. Science 1986; 232: 1540–3
   PubMed Web of Science ®Google Scholar
• Bates S E, Davidson N HE, Valverius E M, et al. Expression of transforming growth factor-a and its mRNA in human breast cancer: its regulation by estrogen and its possible functional significance. Mol Endocrinol 1988; 2: 543–5
   PubMed Web of Science ®Google Scholar
• Clarke R, Lippman M E, Dickson R B. Mechanism of hormone and cytotoxic drug interactions in the development and treatment of breast cancer. Prog Clin Biol Res 1989; 322: 243–78
   Google Scholar
• Clarke R, Katz N., Brünner D, et al. The effects of a constitutive production of TGF-α on the growth of MCF-7 human breast cancer cells in vitro and in vivo. Mol Endocrinol 1989; 3: 372–80
   PubMed Web of Science ®Google Scholar
• Cheville A, Blair O, Clarke R, Gelmann E, Kern F G. Regulation of epidermal growth factor receptor (EGFR) expression in MCF-7 cells EGFR transfectants. (Abstract) 4th Annual Meeting on Oncogenes. 1989
   Google Scholar
• Liu E, Santos G, Lee W MF, Osborne C K, Benz C C. Effects of c-mye overexpression on the growth characteristics of MCF-7 human breast cancer cells. Oncogene 1989; 4: 979–84
   PubMedGoogle Scholar
• Squartini F, Sarnelli R. Structure, functional changes, and proliferative pathology of the human mammary lobule in cancerous breast. JNCI 1981; 67: 33–46
   PubMedGoogle Scholar
• Fondo E Y, Rosen P R, Fracchia A A, Urban J A. The problem of carcinoma developing in fibroadenoma. Cancer 1979; 43: 563–7
   PubMed Web of Science ®Google Scholar
• Buzanowski-Konakry K, Harrison E G, Payne W S. Lobular carcinoma arising in fibroadenoma of the breast. Cancer 1975; 35: 450–6
   PubMedGoogle Scholar
• Salvadori B, Bartoli C, Zurrida S, et al. Risk of invasive cancer in women with lobular carcinoma in situ of the breast. Eur J Cancer 1991; 27: 35–7
   PubMedGoogle Scholar
• Jacquemier J, Kurtz J M, Amalric R, Brandone H, Ayme Y, Spitalier J-M. An assessment of extensive intraductal component as risk factor for local recurrence after breast conserving therapy. Br J Cancer 1990; 61: 873–6
   PubMed Web of Science ®Google Scholar
• Jensen H M. On the origin and progression of human breast cancer. Am J Obstet Gynecol 1986; 154: 1280–4
   PubMedGoogle Scholar
• Enghardt M H, Hale J H. An epithelial and spindle cell breast tumour of myoepithelial origin. Virchows Arch [A] 1989; 416: 177–84
   Web of Science ®Google Scholar
• Wargotz E S, Norris H J. Metaplastic carcinomas of the breast. Cancer 1990; 65: 272–6
   PubMedGoogle Scholar
• Gusterson B A, Warburton M J, Mitchell D, Ellison M, Neville A M, Rudland P S. Distribution of myoepithelial cells and basement membrane proteins in the normal breast and in benign and malignant breast diseases. Cancer Res 1982; 42: 4763–70
   PubMed Web of Science ®Google Scholar
• Russo J, Gusterson B A, Rogers A E, Russo I H, Wellings S R, van Zwieten M J. Biology of disease: comparative study of human and rat mammary tumorigenesis. Lab Invest 1990; 62: 244–78
   PubMed Web of Science ®Google Scholar
• Apter D, Reinila M, Vihko R. Some endocrine characteristics of early menarche, a risk factor for breast cancer, are preserved into adulthood. Int J Cancer 1989; 44: 783–7
   PubMed Web of Science ®Google Scholar
• Thomas D B. Do hormones cause breast cancer?. Cancer 1984; 53: 595–604
   PubMed Web of Science ®Google Scholar
• Ingram D, Nottage E, Ng S, Sparrow L, Roberts A, Willcox D. Obesity and breast cancer. Cancer 1989; 64: 1049–53
   PubMed Web of Science ®Google Scholar
• Tartter P I, Papatestas A E, loannovich J, Mulvihill M N. Cholesterol and obesity as prognostic factors in breast cancer. Cancer 1981; 47: 2222–7
   PubMed Web of Science ®Google Scholar
• Nirmul D, Pegoraro R J, Naidoo C, Joubert S M. The sex hormone profile of male patients with breast cancer. Br J Cancer 1982; 48: 423–7
   Google Scholar
• Adlercreutz H. Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest 1990; 201: 3–23
   Web of Science ®Google Scholar
• Ferguson D JP, Anderson T J. Morphological evaluation of cell turnover in relation to the menstrual cycle in the nesting human breast. Br J Cancer 1981; 44: 177–81
   PubMed Web of Science ®Google Scholar
• Henderson B E, Ross R, Bernstein L. Estrogens as a cause of human cancer. Cancer Res 1988; 48: 246–53
   PubMed Web of Science ®Google Scholar
• Balakrishnan A, Yang J, Beattie C W, Gupta T KD, Nandi S. Estrogen receptor in dissociated and cultured human breast fibroadenoma epithelial cells. Br J Cancer 1987; 34: 233–42
   Google Scholar
• Petersen O W, Hoyer P E, van Deurs B. Frequency and distribution of estrogen receptor-positive cells in normal, nonlactating human breast tissue. Cancer Res 1987; 47: 5748–51
   PubMed Web of Science ®Google Scholar
• Jacquemier J D, Torrente J., Hassoun M, Martin P-M. Distributions of estrogen and progesterone receptors in healthy tissue adjacent to breast lesions at various stages–immuno-histochemical study of 107 cases. Breast Cancer Res Treat 1990; 15: 109–17
   PubMed Web of Science ®Google Scholar
• Clarke R, Dickson R B, Brünner N. The process of malignant progression in human breast cancer. Ann Oncol 1990; 1: 401–7
   PubMed Web of Science ®Google Scholar
• Nowell P C. The clonal evolution of tumor cell populations. Science 1976; 194: 23–8
   PubMed Web of Science ®Google Scholar
• Isaacs J T. Clonal heterogeneity in relation to response. Endocrine management of cancer, B A Stoll. Karger, Basel 1988; Vol. 1: 125–40
   Google Scholar
• Atkinson E N, Brown B W, Montague E D. Tumor volume, nodal status and metastasis in breast cancer in women. JNCI 1986; 76: 171–8
   PubMedGoogle Scholar
• Tannock I F. Principles of cell proliferation: cell kinetics. Cancer: Principles and practice of oncology, V T De Vita, S Hellman, S A Rosenberg. J.B. Lippincott., Philadelphia 1989; 3–13
   Google Scholar
• Harris J R, Henderson I C. Natural history and staging of breast cancer. Breast diseases, J R Harris, S Hellman, I C Henderson, D W Kinne. J.B. Lippincott, Philadelphia 1987
   Google Scholar
• LeClereq G, Heuson J-C. Psychological and pharmacological effects of estrogens in breast cancer. Biochim Biophys Acta 1979; 560: 427–55
   PubMedGoogle Scholar
• Briand P. Hormone-dependent mammary tumors in mice and rats as a model for human breast cancer. Anticancer Res 1983; 3: 273–82
   PubMed Web of Science ®Google Scholar
• Kim U, Depowski M J. Progression from hormone dependence to autonomy in mammary tumors as an in vivo manifestation of sequential clonal selection. Cancer Res 1975; 35: 2068–77
   PubMedGoogle Scholar
• Sluyser M, Van Nie R. Estrogen receptor content and hormone responsive growth of mouse mammary tumors. Cancer Res 1974; 34: 3253–7
   PubMed Web of Science ®Google Scholar
• Manni A, Rainieri J, Arafah B M, Finegan H M, Pearson O H. Role of estrogen and prolactin in the growth and receptor levels of N-nitrosomethylurea-induced rat mammary tumors. Cancer Res 1982; 42: 34925
   Google Scholar
• L'Hermite M, L'Hermite-Baleriaux M. Prolactin and breast cancer. Eur J Cancer Clin Oncol 1988; 24: 955–8
   PubMedGoogle Scholar
• Zhang R, Haag J D, Could M N. Reduction in the frequency of activated ras oncogenes in rat mammary carcinomas with increasing N-methyl-N-nitrosourea doses or increasing prolactin levels. Cancer Res 1990; 50: 4286–90
   PubMedGoogle Scholar
• Sukumar S, Notario V, Martin-Zanca D, Barbacid M. Induction of mammary carcinomas in rats by nitroso-methylurea involves malignant activation of Ha-ras-I locus by single point mutations. Nature 1983; 306: 658–61
   PubMed Web of Science ®Google Scholar
• Zarbl H, Sukumar S, Arthur A V, Martin-Zanca D, Barbacid M. Direct mutagenesis of H-ras-1 oncogenes by N-nitroso-Nmethyulrea during initiation of mammary carcinogenesis in rats. Nature 1985; 315: 382–5
   PubMed Web of Science ®Google Scholar
• Rochlitz C F, Scott G K, Dodson J M, et al. Incidence of activating ras oncogene mutations associated with primary and metastatic human breast cancer. Cancer Res 1989; 49: 357–60
   PubMed Web of Science ®Google Scholar
• Bos J L. ras oncogenes in human cancer: a review. Cancer Res 1989; 49: 4682–9
   PubMed Web of Science ®Google Scholar
• Seibert K, Shafie S M, Triche T J, et al. Clonal variation of MCF-7 breast cancer cells in vitro and in athymic nude mice. Cancer Res 1983; 43: 2223–39
   PubMedGoogle Scholar
• Brünner N, Svenstrup B, Spang-Thompsen M, Bennet P, Nielsen A, Nielsen J J. Serum steroid levels in intact and endocrine ablated Balbc nude mice and their intact litter mates. J Steroid Biochem 1986; 25: 429–32
   PubMedGoogle Scholar
• Ozzello L, Sordat M. Behavior of tumors produced by transplantation of human mammary cell lines in athymic nude mice. Eur J Cancer 1980; 16: 553–9
   PubMedGoogle Scholar
• Shafie S M, Liotta L A. Formation of metastasis by human carcinoma cells (MCF-7) in nude mice. Cancer Lett 1981; 81–7
   PubMedGoogle Scholar
• Levy J A, White A C, McGrath C M. Growth and histology of a human mammary-carcinoma cell line at different sites in the athymic mouse. Br J Cancer 1982; 45: 375–83
   PubMedGoogle Scholar
• Russo J, McGrath C, Russo I H, Rich M A. Tumoral growth of human breast cancer cell line (MCF-7) in athymic mice. Vol I. Prevention and detection of cancer, H E Nieburg. Marcel Dekker, New York 1977; 617–26
   Google Scholar
• Bailey M J, Ormerod M G, Imrie S F, et al. Comparative functional histopathology of human breast carcinoma xenografts. Br J Cancer 1981; 43: 125–34
   PubMedGoogle Scholar
• Giovanella B C, Stehlin J S, Williams L J. Heterotransplantation of human malignant tumors in ‘nude’ thymusless mice. JNCI 1974; 52: 921–27
   PubMedGoogle Scholar
• Price J E, Polyzos A, Zhang R D, Daniels L M. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res 1990; 50: 717–21
   PubMed Web of Science ®Google Scholar
• Liotta L A. Tumor invasion and metastasis: role of the basement membrane. Am J Pathol. 1984; 117: 339–48
   PubMed Web of Science ®Google Scholar
• Kleinman H K, McGarvey M L, Hassell J R, et al. Basement membrane complexes with biological activity. Biochemistry 1986; 25: 312–8
   PubMed Web of Science ®Google Scholar
• Albini A, Iwamoto Y, Kleinman H K, et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987; 47: 3239–45
   PubMed Web of Science ®Google Scholar
• Kramer R H, Bensch K G, Wong J. Invasion of reconstituted basement membrane matrix by metastatic human tumor cells. Cancer Res 1986; 46: 1980–6
   Google Scholar
• Thompson E W, Paik S, Brünner N, et al. Association of increased basement membrane-invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol 1992; 150: 534–44
   PubMed Web of Science ®Google Scholar
• Cattoretti G, Andreola S, Clemente C, D'Amato L, Rilke F. Vimentin and P53 expression in epidermal growth factor receptor-positive oestrogen receptor-negative breast carcinomas. Br J Cancer 1988; 57: 353–7
   PubMed Web of Science ®Google Scholar
• Raymond W, Leong A. AS-Y. Co-expression of cytokeratin and vimentin intermediate filament proteins in benign and neoplastic breast epithelium. J Pathol 1989; 157: 299–306
   PubMed Web of Science ®Google Scholar
• Raymond W A, Leong AS-Y. A new prognostic parameter in breast carcinoma?. J Pathol 1989; 158: 107–14
   PubMed Web of Science ®Google Scholar
• Soule H D, Vasquez J, Long A, Albert S, Brennan M. A human cell line from a pleural effusion derived from a breast carcinoma. JNCI 1973; 51: 1409–16
   PubMed Web of Science ®Google Scholar
• Clarke R, Lippman M E, Dickson R B, Spang-Thompsen M, Brünner N. In vivoin vitro selection of hormone independent cells from the hormone dependent MCF-7 human breast cancer cell line. Immune-deficient animals in experimental medicine, W U.J.B. Zheng. Karger, Basel 1989; 190–5
   Google Scholar
• Clarke R, Brünner N, Katzenellenbogen B S, et al. Progression from hormone dependent to hormone independent growth in MCF-7 human breast cancer cells. Proc Natl Acad Sci USA 1989; 86: 3649–53
   PubMedGoogle Scholar
• Clarke R, Brünner N, Thompson E W., et al. The interrelationships between ovarian-independent growth, antiestrogen resistance and invasiveness in the malignant progression of human breast cancer. J Endocrinol 1989; 122: 331–40
   PubMedGoogle Scholar
• Brünner N, Boulay V, Johnson M D, et al. Expression of estrogen-regulated genes in ovarian-independent sublines of MCF-7 and ZR-75-IB cells. J Cancer Res Clin Oncol 1990; 116(Suppl 1)444
   Google Scholar
• Ghiorghis A, Talebian A, Clarke R. In vitro antineoplastic activity of C7–substituted Mitomycin C analogues (MC-77 and MC-62) against human breast cancer cell lines. Cancer Chemother Pharmacol 1992; 29: 290–6
   PubMedGoogle Scholar
• Clarke R, van den Berg H W, Kennedy D G, Murphy R F. Oestrogen receptor status and the response of human breast cancer cells to a combination of methotrexate and 17β-estradiol. Br J Cancer 1985; 51: 365–9
   PubMedGoogle Scholar
• Bindal R D, Carlson K E, Katzenellenbogen B S, Katzenellenbogen J A. Lipophylic impurities, not phenolsulfonphthalein, account for the estrogenic properties in commercial preparations of phenol red. J Steroid Biochem 1988; 31: 287–93
   PubMedGoogle Scholar
• Gitelman I, Dexter D F, Roder J C. DNA amplification and metastasis of the human melanoma cell line MeWo. Cancer Res 1987; 47: 3851–5
   PubMedGoogle Scholar
• Tlsty T D, Hargolin B M, Lum K. Differences in the rates of gene amplification in nontumorigenic and tumorigenic cell lines as measured by Luria-Delbrück fluctuation analysis. Proc Natl Acad Sci USA 1989; 86: 944–5
   Google Scholar
• Henderson I C, Shapiro C L. Adjuvant chemotherapy: an overview. Medical management of breast cancer, T Powles, I E Smith. Dunitz, London 1991; 197–215
   Google Scholar
• Saceda M, Lippman M E, Chambon P, Lindsey R K, Puente M, Martin M B. Regulation of the estrogen receptor in MCF-7 cells by estradiol. Mol Endocrinol 1988; 2: 1157–62
   PubMed Web of Science ®Google Scholar
• Horwitz K B, Wei L L, Sedlacek S M, d'Arville C N. Progestin action and progesterone receptor structure in human breast cancer: a review. Recent Prog Horm Res 1985; 41: 249–316
   PubMedGoogle Scholar
• Cavaillès V, Augeredu P, Cathepsin H., Rochefort D. gene of human MCF-7 cells contain estrogen-responsive sequences in its 5′ proximal flanking region. Biochem Biophys Res Comm 1991; 174: 816–24
   PubMedGoogle Scholar
• Huff K K, Knabbe C, Lindsey R, et al. Multihormonal regulation of insulin-like growth factor-I-related protein in MCF-7 human breast cancer cells. Mol Endocrinol 1988; 2: 200–8
   PubMedGoogle Scholar
• Knabbe C, Lippman M E, Wakefield L M, Flanders K C, Derynck R, Dickson R B. Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells. Cell 1987; 48: 417–28
   PubMed Web of Science ®Google Scholar